Clinical trial Recruiting at 1 site Observational Ages 16 and up

Registry for monitoring heart conditions

Official title: The Multicenter Cardiology Monitoring Platform Registry (mCMP-registry)

Run by Maastricht University Medical Center · NCT04976348 · Data updated 2026-11-12

This study is collecting health information from people with heart symptoms to see if it can help doctors catch heart problems earlier and understand them better.

More Heart Failure trials

Quick facts

Study typeObservational
Ages16 Years and up
SexAll
Enrollment40000 (estimated)
SponsorMaastricht University Medical Center
Academic / other
Locations1 site (Maastricht, Limburg)
StatusRecruiting
StartedJuly 1, 2021
Main results expectedDecember 2051
Study endsDecember 2051
Registry record updatedOctober 19, 2026
Trial IDNCT04976348 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this registry are individuals aged 16 and older who have been referred for cardiac symptoms or screening.

Probably not a fit

Patients who are unwilling to participate or unable to provide informed consent may not benefit from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The multicenter Cardiology Monitoring Platform registry (mCMP-registry) is a prospective observational registry that collects multi-omics diagnostic measurements as part of routine clinical care. It aims to optimize early diagnosis and risk stratification of cardiovascular diseases, particularly focusing on cardiomyopathy phenotypes, arrhythmias, and coronary artery disease. Participants, aged 16 and older, are referred to cardiology or genetics departments for cardiac symptoms or screening. The registry also includes optional bio-banking and yearly questionnaires to enhance understanding of underlying pathophysiological processes.

Why it matters

Potential benefit: If successful, this registry could lead to improved early diagnosis and management of cardiovascular diseases, ultimately enhancing patient outcomes.

How similar studies have gone: Other observational registries focusing on cardiovascular diseases have shown success in improving diagnosis and treatment strategies, indicating potential for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Referred to the cardiology or genetic department for heart failure like symptoms (as stated in the ESC 2016 Guidelines(3)) or for cardiac/cardiogenetic screening;
* Age ≥16 years.

Exclusion Criteria:

* Unwillingness to participate or unable to give written informed consent (e.g. due to language barriers or severe intellectual disability).

Where it's running

  • Maastricht UMC+
    Maastricht, Limburg, Netherlands
    Recruiting

Study contacts

  • Principal investigator: Hans-Peter Brunner-La Rocca, Prof. — Maastricht University Medical Center
  • Study coordinator: Jerremy Weerts, MD
  • Email: jerremy.weerts@mumc.nl
  • Phone: + 31 43 3871592

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.